Medline, one of the world’s largest suppliers of medical equipment and hospital products, is considering filing for a U.S. IPO as early as late October, according to Bloomberg. The listing could raise about $5 billion and value the Illinois-based company at up to $50 billion. Backed by Blackstone, Carlyle, and Hellman & Friedman, Medline was taken private in a $34 billion buyout in 2021. Goldman Sachs and Morgan Stanley are reportedly leading the offering. A successful IPO would mark one of the largest U.S. healthcare listings in recent years and deliver a significant exit opportunity for its private equity sponsors.
Source: Reuters
